CA-CYOLO
Cyolo, the access company for the digital enterprise, today announced the launch of Cyolo PRO (Privileged Remote Operations), a hybrid secure remote access solution for Operational Technology (OT). Developed specifically to enable safe operations of privileged users, Cyolo PRO is an advanced solution set to redefine Secure Remote Access (SRA) by shifting from managing access to managing operations. Aligning with the core principles of Remote Privileged Access Management (RPAM), Cyolo streamlines access processes providing a hybrid, infrastructure-agnostic solution with a low cost of change. Get Complimentary access to Gartner® report, Securing Remote Privileged Access Management Through RPAM Tools.
"As OT environments change, Cyolo PRO offers a comprehensive set of capabilities tailored to the unique, dynamic needs of organizations operating within these ecosystems. We have been attuned to the requirements emerging from the field, which has driven us to craft a secure, agile, and user-friendly tool,” said Almog Apirion, CEO & Co-founder at Cyolo. “This solution empowers organizations to seamlessly handle remote operations in their core units, without compromising productivity or security."
Cyolo PRO works across environments whether those are cloud-based, cloud-averse or offline. Key features of Cyolo PRO include:
- VPN-less Connectivity with Zero Trust Principles: Cyolo PRO introduces VPN-less connectivity, eliminating the risks associated with network access while adhering to Zero Trust principles.
- Identity Authentication and MFA for Legacy Apps: The solution ensures robust identity authentication, verifying the identity (instead of user) behind the access, even for legacy applications, enhancing overall security measures.
- Granular Access and Actions Management: Cyolo PRO offers granular control over access and actions management using the principles of “least privilege”, providing organizations with a flexible and secure framework.
- Massive Supervision Capabilities: The product includes extensive supervision features and Just in Time access, allowing organizations to monitor and manage remote access effectively.
“Our company has benefited a great deal from Cyolo’s platform,” said Gibson Mark, Senior Systems Administrator at Tata Chemicals. “We’re able to provide seamless remote access to our systems to both internal users and external users. The management overhead of these remote access connections has been greatly reduced. The ease of use of the remote access has been increased for third-party individuals and our internal employees. The adoption rates of these secure remote access methods have gone up substantially since we implemented Cyolo.”
Cyolo PRO is designed to answer the increasing security concerns and complexity around secure remote access in OT environments. Through its solution, Cyolo is empowering organizations with safe, secure and productive remote operations, even in the most demanding mission-critical settings. Its unique capabilities allow organizations to secure access to both internal and third-party users, operating online or offline and in hybrid, on-prem or cloud environments. This comprehensive suite also ensures industry compliance and guarantees uptime, safety and operational integrity.
“With Cyolo PRO’s features, tailored specifically for OT ecosystems, Cyolo is positioning itself as a market leader,” said Joe O’Donnell, Executive Vice President of Corporate Development at Cyolo. “The solution’s capability to seamlessly fit into existing architectures without extensive change management processes is critical in OT environments, as even the slightest change can yield significant consequences.”
Cyolo PRO is now available for enterprises across all critical industries, including manufacturing, oil & gas, utilities, pharmaceuticals, transportation and more. Consolidate your security stack and experience the power of seamless and secure operations across any application in any environment, from legacy infrastructure to cloud environments. Visit https://cyolo.io/ to learn more.
Gartner, Securing Remote Privileged Access Management Through RPAM Tools, Abhyuday Data, Felix Gaehtgens, Michael Kelley, 28 December 2023.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About Cyolo
Cyolo is a leading cybersecurity innovator dedicated to providing cutting-edge access solutions for all environments and deployment scenarios. With a focus on security, operational agility, and user experience, Cyolo is fostering a transition from merely enabling access to empowering operations, productivity, and compliance with its Cyolo PRO (Privileged Remote Operations) solution.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240304157756/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Samsung Epis Holdings Delivers Business Updates at the 44th J.P. Morgan Healthcare Conference15.1.2026 01:40:00 CET | Press release
Samsung Bioepis plans to secure 20 biosimilars in its products and pipeline by 2030The new pipeline will include dupilumab, guselkumab, ixekizumab, fam-trastuzumab deruxtecan-nxki, vedolizumab, and ocrelizumab, in addition to pembrolizumab currently in Phase 1 and 3 clinical studiesHaving secured investigational new drug application (IND) clearance from the U.S. Food and Drug Administration (FDA), SBE303, Samsung Bioepis’ novel antibody-drug conjugate (ADC) engineered to target Nectin-4, will enter into the Phase 1 first-in-human clinical trial this yearSamsung Bioepis plans to add one novel therapeutic candidate in clinical study every year Samsung Epis Holdings (KRX: 0126Z0) today shared corporate progress and updates at the 44th J.P. Morgan Healthcare Conference. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114206458/en/ Kyung-Ah Kim, President and Chief Executive Officer (CEO) of Samsung Epis Holdings "2026 is a mon
Most Delivered Light-Entry Jet Cessna Citation M2 Gen2 With Garmin Autothrottles Enters Into Service, Bringing Greater Control and Precision to Pilots14.1.2026 20:30:00 CET | Press release
The Cessna Citation M2 Gen2 with Garmin Autothrottles recently entered into service. Certified by the Federal Aviation Administration in October 2025, the integration of Garmin’s Autothrottle system in the Citation M2 Gen2 further supports the most delivered light-entry jet’s capabilities by bringing greater control and precision to pilots. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114646844/en/ Most delivered light-entry jet Cessna Citation M2 Gen2 with Garmin Autothrottles enters into service, bringing greater control and precision to pilots (Photo Credit: Textron Aviation). The Cessna Citation M2 Gen2 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company. “We continue to invest in our products to provide customers with the best aviation experience in the world," said Lannie O’Bannion, senior vice president, Sales & Marketing. “The M2 Gen2 leads its segment as the most delivered
TwentyTwo Real Estate and Farallon Capital Complete €761 Million Investment in Isemia, a €1.2bn Healthcare Real Estate Company Created With emeis14.1.2026 18:30:00 CET | Press release
TwentyTwo Real Estate, an independent European real estate investment and management firm, announces the completion, alongside Farallon Capital, of a €761 million investment that led to the creation of Isemia (www.isemiabyemeis.com), a leading healthcare real estate company holding a €1.2 billion portfolio of assets operated by emeis. The transaction represents a significant milestone in TwentyTwo Real Estate’s long-term investment strategy focused on healthcare and operational living real estate. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114262830/en/ Fachklinik Schömberg Isemia comprises 68 high-quality assets across France, Germany and Spain, with a balanced mix of nursing homes (48%) and clinics (52%). The portfolio benefits from strong fundamentals and resilient operating performance. All properties will continue to be operated by emeis under long-term lease agreements, ensuring continuity of care for residents
AI’s Water Demand to Surge Nearly 130% by 2050 – New Research Shows How to Build a Water-Secure AI Economy14.1.2026 16:00:00 CET | Press release
Analysis finds AI could add 30 trillion liters of annual water demand, but targeted reuse and digital infrastructure investments can substantially offset demand and protect communities The rapid global expansion of artificial intelligence is set to drive a 129% increase in water demand across the AI value chain by 2050, according to new research by Xylem (NYSE: XYL) and Global Water Intelligence (GWI). Watering the New Economy: Managing the Impacts of the AI Revolution provides the most comprehensive assessment to date of how AI is reshaping global water use. It also highlights practical ways to meet that demand while strengthening water security for communities. Spending on AI is forecast to approach $2 trillion in 2026,1 accelerating infrastructure build-out worldwide. By the middle of the century, this expansion is projected to add 30 trillion liters of water demand, annually, fueled by a surge in power generation (~54% of the increase), semiconductor fabrication (~42%), and data ce
ACCELQ Crowned Leader and Customer Favorite in The Forrester Wave™ for Autonomous Testing Platforms14.1.2026 16:00:00 CET | Press release
Agentic Test Automation Pioneer Caps Record-Breaking Year of Growth and "AI-Based Engineering Solution of the Year" Honors Forrester has named ACCELQ a Leader in The Forrester Wave™: Autonomous Testing Platforms, Q4 2025. This marks the third consecutive Wave in which ACCELQ has been recognized as a Leader. Notably, this evaluation placed strong emphasis on generative AI innovation and real-world customer adoption. ACCELQ received the highest scores for both capabilities and vision and was the only platform to be recognized as a Customer Favorite, earning a "double halo" for exceptional customer endorsement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260113112861/en/ ACCELQ recognized as a Leader and Customer Favorite in The Forrester Wave™️: Autonomous Testing Platforms, Q4 2025, validating its agentic, GenAI-embedded testing vision. According to the Forrester report, ACCELQ received the highest score among all evaluate
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
